RALYL and colon adenocarcinoma: Analysis of the UALCAN database further revealed that RALYL undergoes hypermethylation in both colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ) [6], accompanied by a downregulation of its expression in these cancer types [6, 7].